Weybosset Research & Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-700
Closed -$226K 52
2024
Q3
$226K Buy
700
+50
+8% +$16.4K 0.08% 46
2024
Q2
$203K Buy
+650
New +$191K 0.08% 45
2024
Q1
Sell
-700
Closed -$202K 46
2023
Q4
$202K Buy
+700
New +$191K 0.07% 45
2023
Q2
Sell
-1,450
Closed -$351K 47
2023
Q1
$351K Hold
1,450
0.13% 35
2022
Q4
$381K Sell
1,450
-400
-22% -$107K 0.15% 33
2022
Q3
$417K Buy
1,850
+400
+28% +$97K 0.18% 31
2022
Q2
$353K Buy
+1,450
New +$355K 0.17% 29
2021
Q4
$405K Buy
1,800
+175
+11% +$36.9K 0.15% 37
2021
Q3
$346K Buy
1,625
+75
+5% +$17.3K 0.14% 37
2021
Q2
$378K Sell
1,550
-25
-2% -$6.15K 0.15% 35
2021
Q1
$392K Hold
1,575
0.16% 34
2020
Q4
$362K Sell
1,575
-150
-9% -$34.6K 0.17% 32
2020
Q3
$438K Hold
1,725
0.24% 30
2020
Q2
$407K Hold
1,725
0.24% 35
2020
Q1
$343K Sell
1,725
-150
-8% -$32.8K 0.24% 35
2019
Q4
$452K Buy
+1,875
New +$413K 0.24% 41
2019
Q3
Sell
-1,875
Closed -$346K 46
2019
Q2
$346K Hold
1,875
0.2% 43
2019
Q1
$356K Buy
1,875
+200
+12% +$38.2K 0.21% 45
2018
Q4
$326K Sell
1,675
-50
-3% -$9.76K 0.22% 43
2018
Q3
$358K Buy
1,725
+75
+5% +$14.8K 0.21% 44
2018
Q2
$305K Hold
1,650
0.18% 47
2018
Q1
$281K Hold
1,650
0.17% 47
2017
Q4
$287K Buy
+1,650
New +$292K 0.17% 49

Other funds holding AMGN

Weybosset Research & Management's AMGN Position: Q4 2024 in Review

Weybosset Research & Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 700 shares — an estimated $226K sold.

Weybosset Research & Management first reported a position in AMGN in Q4 2017 and held it in 23 quarters. The position peaked at $452K in Q4 2019. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Weybosset Research & Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Weybosset Research & Management sold 700 Amgen shares in Q4 2024, an estimated $226K.
  • Weybosset Research & Management first reported a position in Amgen in Q4 2017 and held it in 23 quarters.
  • Weybosset Research & Management's Amgen position peaked at $452K in Q4 2019.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Weybosset Research & Management's 13F filing for Q4 2024, filed 10 Jan 2025.